<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E84079FA-C58D-4F3B-8B5C-E13A603D870A"><gtr:id>E84079FA-C58D-4F3B-8B5C-E13A603D870A</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:surname>Hay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D222D49C-F309-4199-A596-6C5ADEB39DBD"><gtr:id>D222D49C-F309-4199-A596-6C5ADEB39DBD</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>McCauley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117512723"><gtr:id>50A6C64C-C64B-48BA-A90C-69F2F0BE87A6</gtr:id><gtr:title>Reference and surveillance studies of current human and animal influenza viruses and studies of immunity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117512723</gtr:grantReference><gtr:abstractText>The outstanding feature of influenza viruses is their ability to evade host immunity and to cause recurrent annual epidemics of disease, and at infrequent intervals to cause major world-wide pandemics due to the introduction of antigenically novel viruses into an immunologically naive human population. To combat these threats the WHO Global Influenza Surveillance Network monitors the viruses causing outbreaks of influenza throughout the year in different parts of the globe. The principal objectives are 1) the early detection of novel subtypes of influenza A with the potential to cause pandemics, such as the H5N1 viruses isolated in Hong Kong in 1997, and many other countries during 2004-2007, and H9N2 subtype viruses in 1999, respectively, and 2) the identification of antigenic changes among currently circulating influenza A and B viruses, to ensure that influenza vaccines reflect the immunological characteristics of the prevalent viruses. As one of four International WHO Influenza Centres we collaborate in obtaining up to date information on current influenza viruses and advise WHO on the most appropriate vaccine composition.</gtr:abstractText><gtr:technicalSummary>The work concerns viruses causing epidemics, and potentially pandemics, of human disease and the formulation of influenza vaccines, under the auspices of the WHO. Animal and avian influenza viruses are important as potential human pathogens. The objectives are: 1. To monitor and characterise changes in influenza viruses causing epidemics and detect the appearance of novel virus subtypes in both human and animal populations. 2. To assess the serological significance of changes in antigenicity in terms of recommendations for human influenza vaccine composition made by the WHO. To contribute to decisions on the composition of equine influenza vaccines. 3. To relate changes in amino acid sequences of virus components to alterations in the antigenic, biochemical and biological properties of natural virus isolates. Characterisation of virus isolates includes: 1. Antigenic comparisons of the haemagglutinin and neuraminidase components using both polyclonal and monoclonal antibodies. 2. Sequence analyses of virus genes, especially the variable regions of the haemagglutinin. PCR detection of infection in the absence of virus isolation. 3. Studies of changes in biochemical properties such as receptor binding specificity and sensitivity/resistance to anti-influenza drugs. The information obtained on the characteristics of current virus isolates has been used, together with that obtained by the other WHO Influenza Centres, to recommend changes in the components of the trivalent influenza vaccines. Studies of viruses from Hong Kong have led to the detection and characterisation of the novel subtypes, avian H5N1 (1997), avian H9N2 (1999) and swine H3N2 (1999), responsible for causing sporadic human infections. Collaborative studies on antigenic and genetic comparisons of H5N1 viruses, isolated during 2004-2007, have formed the basis of WHO recommendations of pre-pandemic candidate vaccine straines, and have provided information on possible adaptive changes in patients which might contribute to increased transmissibility. Comparisons of the antigenic and genetic characteristics of swine influenza viruses have contributed to our understanding of the diversity and evolution of influenza viruses in pigs in various countries around the world, which may pose a threat to public health. A collaborative project (with Dr. K. Shortridge and Dr. R. Webster) to study the epidemiology and interspecies transmission of avian influenza viruses in Hong Kong was supported by the Wellcome Trust.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1976-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>9192836</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>0F528523-2695-4AB4-8048-821BED4D673D</gtr:id><gtr:impact>Newspaper articles, radio and television (international)

International interest</gtr:impact><gtr:outcomeId>VLhZa7v4C8o</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>125888</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ECDC/HPA Research Grant (CNRL Coordination)2008</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Public Health England</gtr:fundingOrg><gtr:id>597D57A5-301A-4B9A-A802-86AF1C0334C6</gtr:id><gtr:outcomeId>gNzYTQSDUDX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2016)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A5F4929A-0428-4196-8393-C89147EFA575</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de7b05e2730.32085233</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://apps.who.int/iris/bitstream/10665/250513/1/WER9141.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2015)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>40CAE21C-45DE-4E56-8A79-4AC697B73C72</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de6b53e9e10.59247462</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2015/wer9042.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO guidelines on use of anti-influenza drugs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E2B2D3C8-BE84-4C22-810E-E1F9CDA99D51</gtr:id><gtr:impact>Use of anti-influenza drugs during influenza pandemic</gtr:impact><gtr:outcomeId>RZRmNTcDyKf</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (February 2011)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8601D7ED-4F3C-439D-AF9C-9DA3ED4B7277</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de186454e04.12031307</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2011/wer8610/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>JCVI - Influenza</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>ED148593-3860-46F4-AA9A-97895BCC41F4</gtr:id><gtr:impact>Increase in influenza vaccination</gtr:impact><gtr:outcomeId>pC14j6sd7QH</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (February 2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5A9EF042-8772-49D7-A133-2D8E09516C22</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de53e1c4147.42042506</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2014/wer8911.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (February 2012)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F784E89F-C378-435C-BF8B-584591129084</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de399ccc5f5.60775174</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2012/wer8710.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (February 2015)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3FFFB782-74E6-4E2A-8FEB-885D9D1D39CB</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de6398f2e32.73316891</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2015/wer9011.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2010)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>61819220-10BD-4069-BCB9-CE1737D6F647</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de111a4a544.26176109</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2010/wer8541.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2014)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9C6F548D-DDCC-4F81-B7EF-B6136B7A7CA2</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de5dbaaa9f3.94144126</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2014/wer8941.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2013)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2B09EF84-42E3-45E4-82A4-B6C4BBA14FA3</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de4d13b9546.78334556</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2013/wer8841.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (February 2016)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2C997A7B-B3DF-4A5D-8A4C-E5B7BC37740D</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de7370927d9.28687295</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2016/wer9110.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee February 2010</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>16698F09-A242-4DD7-BC37-B5AEF1434D1F</gtr:id><gtr:impact>This meeting makes recommendations for human influenza vaccines</gtr:impact><gtr:outcomeId>589de05b7c11e5.81230132</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2011)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9511F8BF-7699-4558-A554-B3931A49A63B</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de31624d013.50215026</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2011/wer8642.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (February 2013)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3E864168-E27A-4BA5-9065-FCEA9C721E01</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de4716397f2.72712666</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2013/wer8810.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in advisory committee - WHO Influenza Vaccine Selection Committee (September 2012)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>660DF34B-89FF-45AF-8455-BE0D9ED1BA84</gtr:id><gtr:impact>This committee develops recommendations for WHO for human influenza vaccines.</gtr:impact><gtr:outcomeId>589de419ab05f0.64150941</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/wer/2012/wer8741.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>05FC2C73-BB8D-4EC8-95B5-50921032C089</gtr:id><gtr:title>A phospha-oseltamivir-biotin conjugate as a strong and selective adhesive for the influenza virus.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f7ad0c740df7f724753ca657f84a721"><gtr:id>8f7ad0c740df7f724753ca657f84a721</gtr:id><gtr:otherNames>Streicher H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>5457a24298b290.53656298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32536A84-E6B3-4421-BD4F-A5F244B1DDE1</gtr:id><gtr:title>Integrating influenza antigenic dynamics with molecular evolution.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71fafd4a0e8082523ed381695139b36e"><gtr:id>71fafd4a0e8082523ed381695139b36e</gtr:id><gtr:otherNames>Bedford T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5457a243219c47.06624312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C227AB5-C90F-4982-A729-AE3350C985F7</gtr:id><gtr:title>Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007-2008 winter season in Luxembourg: clinical characteristics and epidemiology.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eb847f4795e0a9680aadcd38ac48881"><gtr:id>0eb847f4795e0a9680aadcd38ac48881</gtr:id><gtr:otherNames>Mossong J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn><gtr:outcomeId>f8zRxR56TUn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89D24B37-0435-492E-8DE8-3F1652F309CF</gtr:id><gtr:title>Inefficient transmission of H5N1 influenza viruses in a ferret contact model.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72d7f7040b486a462aa658667f4bd977"><gtr:id>72d7f7040b486a462aa658667f4bd977</gtr:id><gtr:otherNames>Yen HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>8293BAF10FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D7777EF-4721-4FEF-BE64-A83CAD920EB2</gtr:id><gtr:title>Contribution of laboratories in the WHO Eastern Mediterranean Region to the selection of candidate seasonal influenza vaccine, 2010-2015.</gtr:title><gtr:parentPublicationTitle>Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52a25ac24ebedd840746579cc615aced"><gtr:id>52a25ac24ebedd840746579cc615aced</gtr:id><gtr:otherNames>Asghar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1020-3397</gtr:issn><gtr:outcomeId>5a97da39552835.10607915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01E0AB1B-903E-4BF8-842C-3F2E3C364B29</gtr:id><gtr:title>Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b8951d7a3249a0a0476af0ef80120c"><gtr:id>56b8951d7a3249a0a0476af0ef80120c</gtr:id><gtr:otherNames>Benedetti E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>56d9767413a5e5.85297775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99204D57-82B2-4B4E-A0D8-5286E851F0F1</gtr:id><gtr:title>Global circulation patterns of seasonal influenza viruses vary with antigenic drift.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71fafd4a0e8082523ed381695139b36e"><gtr:id>71fafd4a0e8082523ed381695139b36e</gtr:id><gtr:otherNames>Bedford T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d9767482b818.22047990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E5E9288-DB74-45F7-AC32-43EF36932EA5</gtr:id><gtr:title>Future directions for the European influenza reference laboratory network in influenza surveillance.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec9d165416f02b19c807cd0d04485ee2"><gtr:id>ec9d165416f02b19c807cd0d04485ee2</gtr:id><gtr:otherNames>Goddard N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>56d97674376992.21610386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D677126C-D40C-41DA-8792-F3F1C8CD8CE7</gtr:id><gtr:title>Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>Bxf6ooeWB8J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41F2EE3B-AF82-48D5-9763-F65D7EFEA838</gtr:id><gtr:title>Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b97942a0dc3455b46b4f1505ebb84b21"><gtr:id>b97942a0dc3455b46b4f1505ebb84b21</gtr:id><gtr:otherNames>WHO/OIE/FAO H5N1 Evolution Working Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>DDxKmDaDg1L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78ECAD54-8623-407B-997B-AD445BBDBDE9</gtr:id><gtr:title>Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/502b6e35f0c16cd341124a87030af005"><gtr:id>502b6e35f0c16cd341124a87030af005</gtr:id><gtr:otherNames>Lavenu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>B55421C46F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDF49DF4-0157-4660-8D02-6A3EFC1AA99A</gtr:id><gtr:title>Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12c9c6b2d626b090cdc2a554ab05584"><gtr:id>f12c9c6b2d626b090cdc2a554ab05584</gtr:id><gtr:otherNames>Childs RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>Jt7vx3Ec6nS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBE7E722-8454-4515-90A0-7C436D81AEEE</gtr:id><gtr:title>Charting the host adaptation of influenza viruses.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fbe9f7522bdc726f197e55a3d2df077"><gtr:id>1fbe9f7522bdc726f197e55a3d2df077</gtr:id><gtr:otherNames>dos Reis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>KJvHXmHE4mZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA126323-7C03-474F-93A5-40028154E434</gtr:id><gtr:title>Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015.</gtr:title><gtr:parentPublicationTitle>Pathogens (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f59f9a1ca8d2a52d6bd442650547033"><gtr:id>1f59f9a1ca8d2a52d6bd442650547033</gtr:id><gtr:otherNames>Rash A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2076-0817</gtr:issn><gtr:outcomeId>5a97da399f4d22.87573757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>025A13D0-976C-48A0-BD70-689CE730D2D9</gtr:id><gtr:title>Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d93837e152ba0d8414783f02e541b5a9"><gtr:id>d93837e152ba0d8414783f02e541b5a9</gtr:id><gtr:otherNames>Baillie GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15873_23_22013031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAB32082-0CAB-48F6-99E6-D78FD2BE8C4A</gtr:id><gtr:title>Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82a2dbcac62d4ede2d41db7fe8f9e1c1"><gtr:id>82a2dbcac62d4ede2d41db7fe8f9e1c1</gtr:id><gtr:otherNames>Morris DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn><gtr:outcomeId>5a97da3aa0b8b7.69123314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1912EBBB-421D-439D-BA75-61F06A163897</gtr:id><gtr:title>Glyconanoparticles for the plasmonic detection and discrimination between human and avian influenza virus.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17bc5fd6a79c175e734b1be62ff1ed5a"><gtr:id>17bc5fd6a79c175e734b1be62ff1ed5a</gtr:id><gtr:otherNames>Mar?n MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_15873_23_24057694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77F59440-2FC7-4160-ACB9-CB2F80734A63</gtr:id><gtr:title>Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6160af346d3ded771b3c4b5d5f8c0fa"><gtr:id>d6160af346d3ded771b3c4b5d5f8c0fa</gtr:id><gtr:otherNames>Lackenby A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>F4DADD75AA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED101D65-CAE5-4252-A26C-CC76925FCACB</gtr:id><gtr:title>In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance?</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697ab0822d009eb1ccd35b41d9f02362"><gtr:id>697ab0822d009eb1ccd35b41d9f02362</gtr:id><gtr:otherNames>Moules V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>sQMMdMTjsS8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>326EA84F-C482-4E35-8379-5CFCACBBE9D6</gtr:id><gtr:title>Quantifying transmission of highly pathogenic and low pathogenicity H7N1 avian influenza in turkeys.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08f31a54a83b101b09fc432e86211ea3"><gtr:id>08f31a54a83b101b09fc432e86211ea3</gtr:id><gtr:otherNames>Saenz RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15873_23_23028760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F903153-DFF9-4585-B23F-9B57AE45C288</gtr:id><gtr:title>Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>56d976745ea436.83366271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22D2E009-2B4A-4667-BCEE-964FDDBEDE17</gtr:id><gtr:title>Foot-and-mouth disease virus 3C protease induces fragmentation of the Golgi compartment and blocks intra-Golgi transport.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf1ecd4c4c7b837a4d6237fe9fed466"><gtr:id>2bf1ecd4c4c7b837a4d6237fe9fed466</gtr:id><gtr:otherNames>Zhou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>585d77013f0b71.48504082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>108E64DE-1B31-4682-8C91-8444FDDFC2C0</gtr:id><gtr:title>Estimating reassortment rates in co-circulating Eurasian swine influenza viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41bd0455b0592bcf94800a9b8f55c81b"><gtr:id>41bd0455b0592bcf94800a9b8f55c81b</gtr:id><gtr:otherNames>Lycett SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_15873_23_22971819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8F40376-C034-4EF5-A235-C4320C879D2D</gtr:id><gtr:title>High throughput virus plaque quantitation using a flatbed scanner.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5080316229c8050264dc8c1d8bc4c510"><gtr:id>5080316229c8050264dc8c1d8bc4c510</gtr:id><gtr:otherNames>Sullivan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>A2bbKwLrNUT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>423C2EC9-3F2B-4A34-8D90-4C3BCF2763DC</gtr:id><gtr:title>Focused antibody response to influenza linked to antigenic drift.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d699e537f6136ee6954dd5ce72f6d81"><gtr:id>7d699e537f6136ee6954dd5ce72f6d81</gtr:id><gtr:otherNames>Huang KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>56d97674b3dab1.18085285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A336B954-76F9-4D8F-A247-4929182B1A30</gtr:id><gtr:title>Aptamer-based biosensors for the rapid visual detection of flu viruses.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5569830e53257fe80946d6339006dcb8"><gtr:id>5569830e53257fe80946d6339006dcb8</gtr:id><gtr:otherNames>Le TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5457a24122e2b6.10649370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C92E5F05-1C1F-4BFF-BA94-466427676C4D</gtr:id><gtr:title>Identifying changes in selective constraints: host shifts in influenza.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d820b440caeeb320055d46219d4c55a1"><gtr:id>d820b440caeeb320055d46219d4c55a1</gtr:id><gtr:otherNames>Tamuri AU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>BQggbZe1muW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>292E52F3-5086-4938-B092-A9415216B694</gtr:id><gtr:title>Viruses: Model to accelerate epidemic responses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b471f99eec0627add4c6089f3a3091cb"><gtr:id>b471f99eec0627add4c6089f3a3091cb</gtr:id><gtr:otherNames>McCauley JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a97da39c5dad5.98001867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10A5CCD2-8E60-4AB4-AC34-C8CAA1AB4FA4</gtr:id><gtr:title>Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a178cdcbf909e51f538cd7871f85a1f"><gtr:id>6a178cdcbf909e51f538cd7871f85a1f</gtr:id><gtr:otherNames>Yavarian J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn><gtr:outcomeId>eQZFMy9mPbW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EDA1CBD-DD32-467E-91ED-6276E1837FC4</gtr:id><gtr:title>WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8d7f0af59a59e83c78c053634ae1e10"><gtr:id>f8d7f0af59a59e83c78c053634ae1e10</gtr:id><gtr:otherNames>Barr IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5457a242bf2a61.83358576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>260A1527-7826-4877-8580-77A973E5408E</gtr:id><gtr:title>Virus pathotype and deep sequencing of the HA gene of a low pathogenicity H7N1 avian influenza virus causing mortality in Turkeys.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f3a963e90bc06648b07ce0dd4612f0"><gtr:id>77f3a963e90bc06648b07ce0dd4612f0</gtr:id><gtr:otherNames>Iqbal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5457a2434af562.95708615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8224EFFD-3067-4DDA-87A0-F1462A4D25DE</gtr:id><gtr:title>Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5326701fa861c5afae566266fd3de076"><gtr:id>5326701fa861c5afae566266fd3de076</gtr:id><gtr:otherNames>Collins PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>C0849A6F2B4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3B13B49-E4B6-4271-B7AD-4D0A2E249965</gtr:id><gtr:title>Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>5457a241c0c3e3.77270972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F19DE0BA-1885-4387-A790-C2DB49C20261</gtr:id><gtr:title>Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f185ad38cd9ba6b515c35fde7b54609e"><gtr:id>f185ad38cd9ba6b515c35fde7b54609e</gtr:id><gtr:otherNames>Suphaphiphat P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>589ddd679ed0e8.16461813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D2BA4D-B905-4730-B37F-2ABB85FE25B5</gtr:id><gtr:title>Fatal cases of influenza A(H3N2) in children: insights from whole genome sequence analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dd2523a6e157fdb8ac916048af83783"><gtr:id>5dd2523a6e157fdb8ac916048af83783</gtr:id><gtr:otherNames>Galiano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15873_23_22412998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CECAD3FF-F34D-43E8-932D-4065F0F9AF11</gtr:id><gtr:title>Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1c572e79219fc1ba1b0c9e4c4622c8"><gtr:id>fa1c572e79219fc1ba1b0c9e4c4622c8</gtr:id><gtr:otherNames>Moul?s V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>ZRS3mUPtzVB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4475044-DE8B-4727-986F-7708B4C47038</gtr:id><gtr:title>Evaluation of influenza virus antiviral susceptibility testing in Europe: results from the first external quality assessment exercise.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d8c4fa287180c59bb0c47d026e0772"><gtr:id>37d8c4fa287180c59bb0c47d026e0772</gtr:id><gtr:otherNames>Thompson CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>pm_15873_23_23201459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31AF68C8-1DCD-4E8E-B3A2-84926548C110</gtr:id><gtr:title>Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da00b39c70a756a4c88d89a820cd5780"><gtr:id>da00b39c70a756a4c88d89a820cd5780</gtr:id><gtr:otherNames>Puzelli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5457a2414a7723.38340545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE67E420-3277-437C-BCA3-E467E4B691BE</gtr:id><gtr:title>Host factors that interact with the pestivirus N-terminal protease, Npro, are components of the ribonucleoprotein complex.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca86564a12b966ef5a3bb41848fbd123"><gtr:id>ca86564a12b966ef5a3bb41848fbd123</gtr:id><gtr:otherNames>Jefferson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>585d76c08298f4.24752896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15208730-2CAB-4ECA-BA7F-0BD0043E8D80</gtr:id><gtr:title>Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a1ffb256ea1f8a75f52592d7011a432"><gtr:id>2a1ffb256ea1f8a75f52592d7011a432</gtr:id><gtr:otherNames>Zhang XS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>5457a3959ea3e6.20210945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00CCE787-72C4-4587-B98A-30C4ED74EE28</gtr:id><gtr:title>Start of the influenza season 2008-9 in Europe - increasing influenza activity moving from West to East dominated by A(H3N2).</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec9d165416f02b19c807cd0d04485ee2"><gtr:id>ec9d165416f02b19c807cd0d04485ee2</gtr:id><gtr:otherNames>Goddard N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>igZMHkRpKWM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BACCF000-3DEF-4BFB-A061-1A08C7587416</gtr:id><gtr:title>Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f52cf84fd9064586f4036b5cabe2b941"><gtr:id>f52cf84fd9064586f4036b5cabe2b941</gtr:id><gtr:otherNames>Woodward AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>5457a2436f6761.70754713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAF8C9A2-2C78-4B7C-8602-03B423069543</gtr:id><gtr:title>Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8d7f0af59a59e83c78c053634ae1e10"><gtr:id>f8d7f0af59a59e83c78c053634ae1e10</gtr:id><gtr:otherNames>Barr IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>eYY1wzaE1Tu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE733EFC-1818-4A69-AC57-61B3FB316EE8</gtr:id><gtr:title>Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8983c3601e7832edebebc9b332b2a78e"><gtr:id>8983c3601e7832edebebc9b332b2a78e</gtr:id><gtr:otherNames>Pereyaslov D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>56d97673c133a0.00483822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4F72ABF-153C-4BED-9304-DE832A02EC22</gtr:id><gtr:title>M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f02aa2ebb10d042b908ae932541a85e1"><gtr:id>f02aa2ebb10d042b908ae932541a85e1</gtr:id><gtr:otherNames>Cole SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a97da3a387197.35255376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26A0BD1B-2197-4B3A-A34F-33C7D4C630E2</gtr:id><gtr:title>The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn><gtr:outcomeId>589ddd6674c169.54420402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37571C27-20AA-4C52-8CC4-0FCEC9D80264</gtr:id><gtr:title>Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b8b81676e429cf9015a3b58b5620c0"><gtr:id>f9b8b81676e429cf9015a3b58b5620c0</gtr:id><gtr:otherNames>Parker L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>589ddd69466a31.89037653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83AD0996-714F-4996-96FA-F33150F82297</gtr:id><gtr:title>The global circulation of seasonal influenza A (H3N2) viruses.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0b8e1725c014c1320e991217b4813eb"><gtr:id>b0b8e1725c014c1320e991217b4813eb</gtr:id><gtr:otherNames>Russell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>13D4C64939C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A489349E-771C-4F49-9E17-4789F26AC1FC</gtr:id><gtr:title>Enhanced human receptor binding by H5 haemagglutinins.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>5457a2421e0390.68430617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C93C8DB-ABCF-4524-9791-69C3CE918648</gtr:id><gtr:title>WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d3ac03788098acd909e11c6f45f15c2"><gtr:id>0d3ac03788098acd909e11c6f45f15c2</gtr:id><gtr:otherNames>Klimov AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_15873_23_22917957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BBB6FF3-D2F9-4F01-88E0-95B36D9B7CA4</gtr:id><gtr:title>Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac980b5d5b978ec8fce5bcac9c9cdba0"><gtr:id>ac980b5d5b978ec8fce5bcac9c9cdba0</gtr:id><gtr:otherNames>Besselaar TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>815D7811519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B13F629-3CF7-49B4-AA08-EECE8D314404</gtr:id><gtr:title>Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9053fddf2023edbb79fded54e57ef1f"><gtr:id>c9053fddf2023edbb79fded54e57ef1f</gtr:id><gtr:otherNames>Gilsdorf A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>C38C37F800E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D4BC1E6-33C1-4E31-9001-E96080AFBBE1</gtr:id><gtr:title>Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c2dd76535a6547bb6a7d3a1e3b1f470"><gtr:id>7c2dd76535a6547bb6a7d3a1e3b1f470</gtr:id><gtr:otherNames>Richard M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>dFP5ZCoBGHJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>471D38C0-23E6-4B42-A1F8-C6CFDB26D55F</gtr:id><gtr:title>Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00f912b93a39f24dec2b1ab5a406d7c1"><gtr:id>00f912b93a39f24dec2b1ab5a406d7c1</gtr:id><gtr:otherNames>Hurt AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>pm_15873_23_22186145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC22A670-F706-454F-8060-8B912730DA70</gtr:id><gtr:title>Autophagy and formation of tubulovesicular autophagosomes provide a barrier against nonviral gene delivery.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/153d298e7ae040a24d02d71586e4b42b"><gtr:id>153d298e7ae040a24d02d71586e4b42b</gtr:id><gtr:otherNames>Roberts R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>585d772a6c4828.29322922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF2192B4-E14E-400F-A7DC-350B22F4FAF6</gtr:id><gtr:title>Variability in H9N2 haemagglutinin receptor-binding preference and the pH of fusion.</gtr:title><gtr:parentPublicationTitle>Emerging microbes &amp; infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7eee0a25fc2eb23f077ceb3872b798ff"><gtr:id>7eee0a25fc2eb23f077ceb3872b798ff</gtr:id><gtr:otherNames>Peacock TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2222-1751</gtr:issn><gtr:outcomeId>5a97da39e57341.26850601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13D1882C-32AA-43F8-83E4-F2BAE2761DFB</gtr:id><gtr:title>Using non-homogeneous models of nucleotide substitution to identify host shift events: application to the origin of the 1918 'Spanish' influenza pandemic virus.</gtr:title><gtr:parentPublicationTitle>Journal of molecular evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fbe9f7522bdc726f197e55a3d2df077"><gtr:id>1fbe9f7522bdc726f197e55a3d2df077</gtr:id><gtr:otherNames>dos Reis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2844</gtr:issn><gtr:outcomeId>dACgasJqHPQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34CB3ECE-F2E1-4D49-983B-349CCF9BA29B</gtr:id><gtr:title>Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season.</gtr:title><gtr:parentPublicationTitle>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38a2b1b4904183e9a382d29ef60e3384"><gtr:id>38a2b1b4904183e9a382d29ef60e3384</gtr:id><gtr:otherNames>Korsun N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1567-1348</gtr:issn><gtr:outcomeId>589ddd66a00369.92394051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F944A36-E737-4363-A12D-DEECC69E4DF5</gtr:id><gtr:title>Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a6907a5ea850b1b635081bce2c1bd65"><gtr:id>9a6907a5ea850b1b635081bce2c1bd65</gtr:id><gtr:otherNames>Njouom R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>gabdGF2obgC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCCBA30E-0019-4F8F-A207-7E850A9AC953</gtr:id><gtr:title>Genome-wide evolutionary dynamics of influenza B viruses on a global scale.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b3b4951ed0ad196882e8eb917972f94"><gtr:id>5b3b4951ed0ad196882e8eb917972f94</gtr:id><gtr:otherNames>Langat P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a97da3ac49172.29072942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA20968-6408-4FF7-8A8C-7646A820D2AA</gtr:id><gtr:title>Strain-specific antiviral activity of iminosugars against human influenza A viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a2f8e88b4d5243706965b6284b353bd"><gtr:id>6a2f8e88b4d5243706965b6284b353bd</gtr:id><gtr:otherNames>Hussain S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5457a24174c2e2.57701619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28EB7078-5174-45FC-9E44-DAE389DAB5F1</gtr:id><gtr:title>Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da4af43821fe5e6b0480fa84818af932"><gtr:id>da4af43821fe5e6b0480fa84818af932</gtr:id><gtr:otherNames>Uraki R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15873_23_23221570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2027A725-DE5C-41C3-B806-5242CEE10925</gtr:id><gtr:title>Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/615fe9bdcc38d3601b2275731a63a2c0"><gtr:id>615fe9bdcc38d3601b2275731a63a2c0</gtr:id><gtr:otherNames>Meijer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>UfiCZt9mNB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>630DDED2-B283-4A66-9922-77D2E9B39381</gtr:id><gtr:title>Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41e38ff2130fe1130edb99e56aab084b"><gtr:id>41e38ff2130fe1130edb99e56aab084b</gtr:id><gtr:otherNames>Hampson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a97da397bf017.09652372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17858E55-35B0-44A1-B599-8616AA2E17B9</gtr:id><gtr:title>A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f94ede5326fdc10a9a00c4996598664e"><gtr:id>f94ede5326fdc10a9a00c4996598664e</gtr:id><gtr:otherNames>Escuret V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5457a242734206.09983825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AED4DF8-1DD5-4247-B0A5-4EDB27016F1F</gtr:id><gtr:title>An efficient genome sequencing method for equine influenza [H3N8] virus reveals a new polymorphism in the PA-X protein.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f59f9a1ca8d2a52d6bd442650547033"><gtr:id>1f59f9a1ca8d2a52d6bd442650547033</gtr:id><gtr:otherNames>Rash A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn><gtr:outcomeId>5457a2419b9fb1.25128344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2495B357-6DE9-4356-ABB1-94A9CBB1E3EC</gtr:id><gtr:title>Influenza virus survival in aerosols and estimates of viable virus loss resulting from aerosolization and air-sampling.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75a267ef65956748d1b5fdaaa9a2c67"><gtr:id>a75a267ef65956748d1b5fdaaa9a2c67</gtr:id><gtr:otherNames>Brown JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn><gtr:outcomeId>56d97673e22811.67571383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7E774D8-80B3-4185-ADB8-0CB822E1BE98</gtr:id><gtr:title>Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e2fa2000094fa04ed67ce189edff78b"><gtr:id>5e2fa2000094fa04ed67ce189edff78b</gtr:id><gtr:otherNames>Groves HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a97da3b03d161.41842210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7693EBD3-6BE1-4238-8A57-793D0C54463B</gtr:id><gtr:title>Infection and pathogenesis of canine, equine, and human influenza viruses in canine tracheas.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eeb2e7376eff49b498b32f25ef970b"><gtr:id>65eeb2e7376eff49b498b32f25ef970b</gtr:id><gtr:otherNames>Gonzalez G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5457a241ea03b8.03631932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0F6FFB2-E5B4-43C2-A6E6-0C536C763D1E</gtr:id><gtr:title>Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/615fe9bdcc38d3601b2275731a63a2c0"><gtr:id>615fe9bdcc38d3601b2275731a63a2c0</gtr:id><gtr:otherNames>Meijer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>UXWQ3Wu8Uft</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>063CAA17-E1E7-4817-B8E7-77CDD576AE6A</gtr:id><gtr:title>Optimization of a Quantitative Micro-neutralization Assay.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>589ddd66d86645.23861238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3154FE8-FC14-4F48-8D4B-9C6F18B20B92</gtr:id><gtr:title>Selection of antigenically advanced variants of seasonal influenza viruses.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9a3aa67a5e6a2ba5c8d8092e120270b"><gtr:id>d9a3aa67a5e6a2ba5c8d8092e120270b</gtr:id><gtr:otherNames>Li C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>589ddd67100d94.83112550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>534FBA33-8149-41AA-9C2C-07A56340E1FD</gtr:id><gtr:title>Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a93d98eafc315fd152ec1120e6f06e"><gtr:id>77a93d98eafc315fd152ec1120e6f06e</gtr:id><gtr:otherNames>Glatman-Freedman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>5a97da3a832d14.00752790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE951F4B-F21A-429F-A9A7-6C6B564AD1F9</gtr:id><gtr:title>Receptor binding by a ferret-transmissible H5 avian influenza virus.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15873_23_23615615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE731733-CFF1-4A87-8373-1949A8F1D3F6</gtr:id><gtr:title>Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c2dd76535a6547bb6a7d3a1e3b1f470"><gtr:id>7c2dd76535a6547bb6a7d3a1e3b1f470</gtr:id><gtr:otherNames>Richard M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>49B670508A5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63C16DB0-0B75-49A4-882C-B1F8A8288D5B</gtr:id><gtr:title>Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64b6d3888aa253092661ec6f881fc031"><gtr:id>64b6d3888aa253092661ec6f881fc031</gtr:id><gtr:otherNames>Harvey WT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>589ddd67c44ad3.35856049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91CF36AA-3CB1-42BD-B132-752F89A24C27</gtr:id><gtr:title>Receptor binding by H10 influenza viruses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b4c687eb15e5d35fe0acbde92cd5152"><gtr:id>0b4c687eb15e5d35fe0acbde92cd5152</gtr:id><gtr:otherNames>Vachieri SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5457a24249bb47.12592225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF889DD0-46B1-4CCA-A264-E1310C26AC51</gtr:id><gtr:title>Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0b8e1725c014c1320e991217b4813eb"><gtr:id>b0b8e1725c014c1320e991217b4813eb</gtr:id><gtr:otherNames>Russell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5B70081BD0B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F19A29E-8B40-44D9-ADEA-4F70F545BBC1</gtr:id><gtr:title>Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/898bdc5547c14d256780b33b77647245"><gtr:id>898bdc5547c14d256780b33b77647245</gtr:id><gtr:otherNames>Monto AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>11215F42FCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF3FAA98-ED53-4C4C-921D-83078FFB8E38</gtr:id><gtr:title>Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/872d57009536cbd18bd62d57c4c7ca98"><gtr:id>872d57009536cbd18bd62d57c4c7ca98</gtr:id><gtr:otherNames>Broberg E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>5457a242e9c316.12775833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4C5536-B3B1-4147-98F4-5197438B14D0</gtr:id><gtr:title>Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/615fe9bdcc38d3601b2275731a63a2c0"><gtr:id>615fe9bdcc38d3601b2275731a63a2c0</gtr:id><gtr:otherNames>Meijer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn><gtr:outcomeId>pm_15873_23_22971326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>184CFF59-7D22-4C89-B29E-06FB10ED09E3</gtr:id><gtr:title>Identification and characterization of a late AH1N2 human reassortant in France during the 2002-2003 influenza season.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b8062938e3650f8cb1596ad117873f6"><gtr:id>8b8062938e3650f8cb1596ad117873f6</gtr:id><gtr:otherNames>Al Faress S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>6ABED28F655</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117512723</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>